The NHS Commissioning Board (operating under the name of NHS England)
NHS National Pharmaceuticals - Everolimus and terminated agreement products
This is a contract result notice, not an open opportunity. Details from the official award data.
Potential periods of call-offs under the framework agreement:Everolimus: All regions: to commence as soon as possible with an end date of 01/03/2022Oral Products: All regions: to commence as soon as possible with an end date of 28/02/2022Hospital Only Products: DLS, DNE, DNW, DLN and DSW regions: to commence as soon as possible with an end date 31/01/2022
Make the case to bid
Reveal who to approach at The NHS Commissioning Board (operating under the name of NHS England), and generate a go-to-market strategy from their news, accounts and people.
Ask me about this tender, the buyer, who wins their work, or whether you should bid.
- OCID
- ocds-h6vhtk-02a471
- Stage
- award · Awarded
- Source
- Find a Tender
- Buyer ref
- 024061-2021
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Medical Equipment & Pharmaceuticals
The NHS Commissioning Board (operating under the name of NHS England)’s tender network
Assembling the network…